Adherence to Guidelines for Antibiotic Use in Respiratory Infections at Hospitals
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to test a strategy to improve the quality of antibiotic use in lower respiratory tract infections (LRTIs) at hospitals. Therefore, a multifaceted intervention strategy is compared to a control strategy and the effectiveness and feasibility of the intervention is assessed.
| Condition | Intervention |
|---|---|
|
Pneumonia Chronic Bronchitis COPD |
Behavioral: Professional education Behavioral: Implementation of a Critical Care Pathway Behavioral: Professional audit and feedback Behavioral: Process analysis and redesign |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Educational/Counseling/Training |
| Official Title: | Prevention of Antimicrobial Resistance in Hospitals: Promoting Appropriate Use of Antibiotics in Hospital Departments of Internal and Pulmonary Medicine |
- adherence to key quality indicators for antibiotic use in lower respiratory tract infections (indicators were developed from current [inter]national guideline recommendations and a systematic review of the literature)
- cost
- process evaluation: how well was the intervention performed
- length of hospital stay
- in-hospital mortality
- Intensive Care Unit (ICU)-transfer
- 30 day re-admission rate
| Estimated Enrollment: | 2000 |
| Study Start Date: | September 2002 |
| Estimated Study Completion Date: | April 2005 |
Improving processes of care in patients with hospital LRTI has been related to better patient outcome. Inappropriate use of antibiotics has contributed to the emergence and spread of drug-resistant micro organisms and increased treatment costs. International guidelines provide recommendations for the initial evaluation and management of LRTI, including advice on judicious antibiotic therapy. Nonetheless, studies have demonstrated a wide variability in adherence to these guidelines.
To implement key recommendations in clinical practice, various strategies have been used, with mixed results. Perhaps the most important aspect of choosing a potentially effective intervention is that the choice of intervention should be based upon assessment of potential barriers in the target group. Many intervention studies are flawed by failing to control for secular trends.
The investigators performed a cluster randomised controlled trial, to study the effect of a multifaceted intervention strategy on the quality of antibiotic use for LRTI. Their intervention was tailored to the areas most in need for improvement and took perceived barriers in the target group into consideration at the individual hospital level.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Patients admitted to a respiratory care or internal medicine ward with community-acquired pneumonia or acute exacerbation of chronic bronchitis or chronic obstructive pulmonary disease (COPD)
Exclusion Criteria:
- Recent (< 30 days) admission for LRTI
- Patients with underlying immunodeficiency (HIV infection, neutropenia, treatment with immunomodulating drugs, active hematological malignancies, anatomical or functional asplenia and hypogammaglobulinemia)
- Patients already on treatment with antibiotics for another culture proven infection at the time of admission
- Patients from nursing homes
- Patients who had been transferred to another hospital or ICU and patients who had died within 24 hours of admission
- Patients with very poor prognosis (life expectancy < 2 weeks on admission).
Contacts and Locations| Netherlands | |
| Gelre Ziekenhuizen | |
| Apeldoorn, Netherlands | |
| Deventer Ziekenhuis | |
| Deventer, Netherlands | |
| Ziekenhuis Gelderse Vallei | |
| Ede, Netherlands | |
| Bernhoven Ziekenhuis | |
| Oss, Netherlands | |
| Bernhoven Ziekenhuis | |
| Veghel, Netherlands | |
| Maxima Medisch Centrum | |
| Veldhoven, Netherlands | |
| Vie Curi Medisch Centrum | |
| Venlo, Netherlands | |
| Principal Investigator: | Marlies E Hulscher, MSc, PhD | Centre for Quality of Care Research, Radboud University Nijmegen Medical Centre |
| Study Director: | Richard P Grol, MSc, PhD | Centre for Quality of Care Research, Radboud University Nijmegen Medical Centre |
| Study Director: | Jos WM van der Meer, MD, PhD | Department of General Internal Medicine, Radboud University Nijmegen Medical Centre |
More Information
Additional Information:
No publications provided
| ClinicalTrials.gov Identifier: | NCT00129883 History of Changes |
| Other Study ID Numbers: | AGAR-2001-1, ZonMw grant no. 2300.0024 |
| Study First Received: | August 11, 2005 |
| Last Updated: | September 26, 2005 |
| Health Authority: | Netherlands: The Central Committee on Research Involving Human Subjects (CCMO) |
Keywords provided by Radboud University:
|
quality of care antibiotic use intervention |
lower respiratory tract infections Community acquired Pneumonia Acute Exacerbation of Chronic Bronchitis or COPD |
Additional relevant MeSH terms:
|
Bronchitis Bronchitis, Chronic Pulmonary Disease, Chronic Obstructive Pneumonia Respiratory Tract Infections Bronchial Diseases Respiratory Tract Diseases |
Lung Diseases, Obstructive Lung Diseases Infection Anti-Bacterial Agents Anti-Infective Agents Therapeutic Uses Pharmacologic Actions |
ClinicalTrials.gov processed this record on May 22, 2013